Check out the full article here!

How Telaspot by Steth IO is creating scalable, continuous care solutions that work for small practices and large health systems alike The COVID-19 pandemic provided the motivation for rapid adoption of telehealth and remote patient monitoring across the U.S., but the utility of such digital health solutions extends beyond the pandemic—with 65 percent of providers agreeing that telehealth will remain just as or more important following the pandemic.  Why? Done right, telemedicine can offer an all-in-one solution designed to improve

Healthcare costs in the US have steadily risen for decades, accounting for $3.8 trillion or 17.7 percent of the country’s GDP. Because of this, one in five Americans skip or have skipped needed healthcare due to cost concerns—leading to a need for cost intervention. With certain changes, telemedicine platforms can help reduce healthcare costs at a scalable level to accomplish significant cost savings for payers, providers, and patients alike. The challenges with our current high-cost, low efficacy telemedicine system Today’s

Every two months, Newchip hosts a week-long online conference that combines the best expert-led panels with a demo showcase of our global startup portfolio. These conferences are free and open for investors, potential partners, and new entrepreneurs – and this week, we are excited that StethIO’s President & CEO, Dr. Mahesh Mulumudi, MD, is among the presenters. You can learn more by visiting Newchip’s site!